|
Volumn 41, Issue 3, 2011, Pages 296-297
|
Atopic dermatitis: New trends and perspectives
|
Author keywords
Atopic dermatitis; Cytokine; Immune cells; Keratinocyte
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
BETA DEFENSIN;
CALCINEURIN INHIBITOR;
CATHELICIDIN;
CYCLOSPORIN A;
EMOLLIENT AGENT;
GAMMA INTERFERON;
GLUCOCORTICOID;
HISTAMINE H4 RECEPTOR;
IMMUNOGLOBULIN E;
INTERFERON;
INTERLEUKIN 21;
INTERLEUKIN 25;
INTERLEUKIN 31;
INTERLEUKIN 33;
PROBIOTIC AGENT;
THYMIC STROMAL LYMPHOPOIETIN;
TRYPTASE;
TUMOR NECROSIS FACTOR ALPHA INHIBITOR;
ADAPTIVE IMMUNITY;
ATOPIC DERMATITIS;
B LYMPHOCYTE;
B LYMPHOCYTE ACTIVATION;
CORTICOSTEROID THERAPY;
EOSINOPHIL;
HUMAN;
IMMUNE DYSREGULATION;
IMMUNOPATHOGENESIS;
INHIBITION KINETICS;
INNATE IMMUNITY;
KERATINOCYTE;
LANGERHANS CELL;
LEUKOCYTE ACTIVATION;
MAST CELL;
NERVE CELL;
NEUROGENIC INFLAMMATION;
NEUROTRANSMITTER RELEASE;
PATHOPHYSIOLOGY;
PHOTOTHERAPY;
PLASMACYTOID DENDRITIC CELL;
REVIEW;
SKIN PRURITUS;
STRESS;
SUPERINFECTION;
T LYMPHOCYTE;
TH2 CELL;
DERMATITIS, ATOPIC;
HUMANS;
|
EID: 80054887587
PISSN: 10800549
EISSN: 15590267
Source Type: Journal
DOI: 10.1007/s12016-010-8247-6 Document Type: Review |
Times cited : (10)
|
References (10)
|